U.S. Chemicals Stock News

Earlier in 2026, BrightSpring Health Services held its Annual Meeting of Stockholders, electing three Class II directors through 2029, ratifying KPMG as auditor for 2026, and securing shareholder approval for its executive compensation program. A separate update highlighted that, since its Nasdaq debut in January 2024, BrightSpring’s shares have risen by a very large amount alongside increased full-year 2026 revenue and adjusted EBITDA guidance following robust quarterly results. Now we’ll...

Parsons Corporation recently served as lead designer for Los Angeles Metro’s D Line Subway Extension Section 1, now open and adding 3.9 miles of rail and three new underground stations between Wilshire/Western and Beverly Hills, while also securing a new US$136 million-ceiling architect-engineer contract at Hill Air Force Base. These projects highlight Parsons’ role in complex transit and defense infrastructure, expanding its visibility across urban mobility, cultural access, and long-term...

Earlier this month, GEO Group reported first-quarter results showing a 16.6% year-on-year revenue increase, beating analyst expectations and prompting management to raise full-year guidance. The combination of stronger-than-expected earnings, an upgraded outlook, and improving business services demand highlights how GEO Group is benefiting from shifting security and detention needs amid easing geopolitical risks. Next, we’ll examine how this upgraded full-year guidance and earnings strength...

Viking Holdings (VIK) is back in focus after first quarter results showed higher revenue, improved operating margins, and increased passenger volumes, alongside strong 2026 bookings and an analyst upgrade highlighting potential yield growth. See our latest analysis for Viking Holdings. The first quarter update and leadership changes have come against a backdrop of solid momentum, with a year to date share price return of 16.55% and a 1 year total shareholder return of 92.44%, suggesting...

In May 2026, Wolverine World Wide reported first-quarter 2026 results showing sales of US$457.6 million and net income of US$20.2 million, alongside raising its full-year 2026 earnings guidance while keeping revenue expectations of about US$1.96 billion to US$1.99 billion unchanged. Alongside this earnings upgrade, shareholders voted against a proposed new climate policy, highlighting a gap between parts of the investor base and current board-level priorities on sustainability. Next, we will...

What recent performance suggests about GeneDx Holdings GeneDx Holdings (WGS) has drawn attention after a mixed run in its stock, with the price roughly flat over the past day, up about 16% over the past week, yet down over the past month and past 3 months. See our latest analysis for GeneDx Holdings. Looking beyond the recent bounce, the stock has a 7-day share price return of 16.1%, but the 30-day and year to date share price returns are down 31.0% and 64.2% respectively, while the 3-year...

CME Group (CME) has drawn investor interest after recent trading in the stock, with a last close of $291.23 and a market value of about $105.5b, prompting a closer look at fundamentals. See our latest analysis for CME Group. Recent trading has been choppy, with the 7 day share price return down 4.55% and the 90 day share price return down 8.71%. However, the year to date share price return of 7.99% and a 3 year total shareholder return of 87.62% still point to longer term momentum. If CME...

NCR Atleos has expanded its Cashzone ATM network into Colombia, partnering with Bancoomeva as sponsoring and settlement bank to provide compliant, reliable cash access nationwide. This move extends Cashzone’s presence to 14 countries and reinforces NCR Atleos’ role in supporting financial inclusion where both cash and digital payments remain important. Next, we’ll explore how this Colombia expansion, supported by Bancoomeva and aligned with Asobancaria’s priorities, may influence NCR Atleos’...

Recent performance context for Spyre Therapeutics (SYRE) Spyre Therapeutics (SYRE) has drawn increased attention after a strong stock performance over the past 3 months and year to date, prompting investors to reassess what the current price implies. See our latest analysis for Spyre Therapeutics. The recent surge, including a 70.43% 90 day share price return and very large 3 year total shareholder return, points to strong momentum, even though the latest 1 day move was slightly weaker. If...

In May 2026, Cavco Industries reported higher fourth-quarter and full-year sales and earnings, authorized a new US$150 million share repurchase program after completing US$82.23 million of prior buybacks, and advanced construction plans for a large home manufacturing facility in El Mirage, Arizona. Together, the record home shipments, expanded production footprint, and continued capital returns highlight how Cavco is simultaneously investing for growth while tightening its share base. Next,...

In recent months, Strategy Inc, founded by Michael Saylor, has signalled that it may sell part of its roughly 850,000‑Bitcoin treasury, marking a departure from its long‑standing “never sell” stance amid continued net losses and balance sheet pressure. This potential shift toward tactical Bitcoin sales, aimed at maximizing Bitcoin per share and funding obligations, could materially change how investors assess Strategy’s role as a publicly listed Bitcoin proxy. We’ll now examine how the...

Vulcan Materials (VMC) reaffirmed its adjusted EBITDA outlook after reporting a 5% rise in first quarter aggregates shipments, which ties the stock closely to ongoing public construction and a healthy project backlog. See our latest analysis for Vulcan Materials. Despite reaffirming its outlook and reporting growth in aggregates shipments, Vulcan Materials’ share price has eased recently. The 30 day share price return is down 10.76% and the 90 day share price return is down 18.01%, while the...

In recent weeks Ameresco reported quarterly results showing 13.8% year-on-year revenue growth and a roughly 20% increase in awarded backlog to almost US$2.80 billion, even as it missed full-year EBITDA guidance and analysts’ EPS estimates. At the same time, a series of insider option exercises and sales plus the launch of the Neogenyx Fuels renewable natural gas joint venture in Nebraska have raised fresh questions about how Ameresco is balancing growth investments with near-term...

Earlier this month, Monster Beverage Corporation announced that its board had authorized a new share repurchase program of up to US$500 million, following a quarter in which it also returned US$100 million to shareholders through buybacks alongside strong reported growth in net sales and net income per diluted share. This combination of robust recent financial results, continued capital returns, and evident institutional investor interest has put renewed attention on how Monster Beverage...

In May 2026, Cisco Systems reported third-quarter revenue of US$15,841 million and net income of US$3,373 million, alongside confirming guidance, ongoing share buybacks, and a US$0.42 quarterly dividend. At the same time, Cisco deepened its role in AI infrastructure and security through collaborations like Automation Anywhere’s EnterpriseClaw and an expanded open optical connectivity initiative for AI data centers. We’ll now examine how Cisco’s stronger AI infrastructure outlook and...

Recent performance context for Graco stock Without a specific headline event to focus on, Graco (GGG) has recently drawn investor attention as the stock trades around its last close of US$75.63, following mixed short term and longer term return patterns. Over the past month the stock declined about 7%, and over the past 3 months it fell roughly 19%. The 1 year total return is down about 8%. By contrast, the 3 year total return is about 2% and the 5 year total return is about 6%, giving...

McEwen (NYSE:MUX) is back in focus after reporting a US$49.4 million dividend from the San José Mine in Argentina. This payout surpassed its full year expectations and lifted available cash resources. See our latest analysis for McEwen. Despite the cash inflow from San José, recent trading has been softer, with the share price down about 21.6% over the past 90 days, even after a positive year to date share price return of 13.2% and a very strong 1 year total shareholder return of about 166%...

Marex Group (MRX) has secured the required consents from holders of its 6.404% Senior Notes due 2029 to amend the indenture, a key step in its proposed redomiciliation to Bermuda. See our latest analysis for Marex Group. The consent win comes as the stock trades at US$53.20, with the share price return up 33.17% over 90 days and 40.22% year to date, while the 1 year total shareholder return is 20.87%. This suggests momentum has been building despite some recent short term share price...

In May 2026, the Physician Association of California and Astrana Health announced a collaboration to support independent primary care physicians using Astrana’s in-house, AI-powered platform that integrates care delivery, data, and financial infrastructure to streamline accountable care participation. This partnership highlights Astrana’s effort to deepen its role in value-based healthcare by reducing administrative burden for small practices while enhancing population health capabilities...

Capital Southwest Corporation recently reported full-year results for the period ended March 31, 2026, with revenue rising to US$232.11 million and net income increasing to US$113.00 million, alongside higher basic and diluted earnings per share from continuing operations. Despite authorizing a buyback program in 2021, the company did not repurchase any shares in the latest quarter, meaning all of the earnings-per-share improvement came from operating performance rather than share count...

Macy's (M) stock has drawn fresh attention after recent trading, with the share price closing at US$20.66 and short-term returns mixed over the past week, month, and past 3 months. Investors are reassessing valuation and performance. See our latest analysis for Macy's. The recent 11.56% 7 day share price return sits against a year to date share price decline of 9.19%, while the 1 year total shareholder return of 86.80% points to meaningful longer term gains. This suggests that momentum has...

Huntington Ingalls Industries (HII) is back in the spotlight after showcasing its unmanned maritime platforms and Odyssey autonomy software at the Combined Naval Event 2026, alongside recent U.S. Marine Corps contract execution. See our latest analysis for Huntington Ingalls Industries. Despite the recent focus on autonomy and new defense contracts, the share price has eased, with a 30 day share price return down 10.76% and a 90 day share price return down 26.80%, while the 1 year total...

Earlier in 2026, Lucid Group announced that Uber will raise its total investment in the company to US$500 million and commit to purchasing at least 35,000 Lucid vehicles, while an affiliate of Saudi Arabia’s Public Investment Fund injected an additional US$550 million. This combination of fresh capital and a large, multi-year fleet order ties Lucid directly into Uber’s planned global robotaxi network, potentially reshaping how its technology and manufacturing capacity are used. Next, we’ll...

Driven Brands Holdings (DRVN) is back in focus after reporting fourth quarter and full year 2025 results that showed a shift from prior losses to profitability, along with higher reported sales and revenue. See our latest analysis for Driven Brands Holdings. The recent move back into profit has coincided with a 1 month share price return of 8.77% and a 7 day gain of 5.92%. However, the 1 year total shareholder return is still down 20.03% and the 5 year total shareholder return has declined...